Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
David Ellison and colleagues report whole-genome sequencing of pediatric low-grade gliomas, the most common pediatric brain tumor. They identify a range of genomic alterations, including recurrent and mutually exclusive duplications of the FGFR1 region encoding the tyrosine kinase domain and rearran...
Saved in:
| Published in: | Nature genetics Vol. 45; no. 6; pp. 602 - 612 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
New York
Nature Publishing Group US
01.06.2013
Nature Publishing Group |
| Subjects: | |
| ISSN: | 1061-4036, 1546-1718, 1546-1718 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | David Ellison and colleagues report whole-genome sequencing of pediatric low-grade gliomas, the most common pediatric brain tumor. They identify a range of genomic alterations, including recurrent and mutually exclusive duplications of the
FGFR1
region encoding the tyrosine kinase domain and rearrangements of
MYB
.
The most common pediatric brain tumors are low-grade gliomas (LGGs). We used whole-genome sequencing to identify multiple new genetic alterations involving
BRAF
,
RAF1
,
FGFR1
,
MYB
,
MYBL1
and genes with histone-related functions, including
H3F3A
and
ATRX
, in 39 LGGs and low-grade glioneuronal tumors (LGGNTs). Only a single non-silent somatic alteration was detected in 24 of 39 (62%) tumors. Intragenic duplications of the portion of
FGFR1
encoding the tyrosine kinase domain (TKD) and rearrangements of
MYB
were recurrent and mutually exclusive in 53% of grade II diffuse LGGs. Transplantation of
Trp53
-null neonatal astrocytes expressing
FGFR1
with the duplication involving the TKD into the brains of nude mice generated high-grade astrocytomas with short latency and 100% penetrance.
FGFR1
with the duplication induced FGFR1 autophosphorylation and upregulation of the MAPK/ERK and PI3K pathways, which could be blocked by specific inhibitors. Focusing on the therapeutically challenging diffuse LGGs, our study of 151 tumors has discovered genetic alterations and potential therapeutic targets across the entire range of pediatric LGGs and LGGNTs. |
|---|---|
| Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
| ISSN: | 1061-4036 1546-1718 1546-1718 |
| DOI: | 10.1038/ng.2611 |